Publications by authors named "Anish Thomas"

100Publications

Population pharmacokinetic analysis of nanoparticle-bound and free camptothecin after administration of NLG207 in adults with advanced solid tumors.

Cancer Chemother Pharmacol 2020 Oct 8;86(4):475-486. Epub 2020 Sep 8.

Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 10/Room 5A03, Bethesda, MD, 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-020-04134-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515962PMC
October 2020

Enhanced efficacy of mesothelin-targeted immunotoxin LMB-100 and anti-PD-1 antibody in patients with mesothelioma and mouse tumor models.

Sci Transl Med 2020 Jul;12(550)

Thoracic and GI Malignancies Branch, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.aaz7252DOI Listing
July 2020

Lenvatinib for thymic carcinomas.

Lancet Oncol 2020 06;21(6):745-746

Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, 20892, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(20)30213-8DOI Listing
June 2020

F-FDG PET Assessment of Malignant Pleural Mesothelioma: Total Lesion Volume and Total Lesion Glycolysis-The Central Role of Volume.

J Nucl Med 2020 Nov 13;61(11):1570-1575. Epub 2020 Apr 13.

Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.119.238733DOI Listing
November 2020

Intracardiac Involvement by Primary Malignant Mesothelioma: A Report of Two Cases.

J Thorac Oncol 2020 02;15(2):e25-e27

Developmental Therapeutics Branch, National Cancer Institute, Bethesda, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.08.2504DOI Listing
February 2020

Use of Magnetic Resonance Imaging to Identify Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis.

JAMA Netw Open 2020 02 5;3(2):e200032. Epub 2020 Feb 5.

Office of the Clinical Director, Intramural Research Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamanetworkopen.2020.0032DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137682PMC
February 2020

Targeting DNA Repair to Drive Immune Responses: It's Time to Reconsider the Strategy for Clinical Translation.

Clin Cancer Res 2020 Jun 17;26(11):2452-2456. Epub 2020 Feb 17.

Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-19-3841DOI Listing
June 2020

Are neuroendocrine negative small cell lung cancer and large cell neuroendocrine carcinoma with WT RB1 two faces of the same entity?

Lung Cancer Manag 2019 Aug 21;8(2):LMT13. Epub 2019 Aug 21.

National Cancer Institute, Division of Cancer Treatment & Diagnosis, Rockville, MD 20850, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/lmt-2019-0005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802707PMC
August 2019

Reply to Yan et al.

Authors:
Anish Thomas

J Thorac Oncol 2019 10;14(10):e245-e246

National Cancer Institute, Bethesda, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.08.001DOI Listing
October 2019

Targeting Topoisomerase I in the Era of Precision Medicine.

Clin Cancer Res 2019 11 21;25(22):6581-6589. Epub 2019 Jun 21.

Developmental Therapeutics Branch, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-19-1089DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858945PMC
November 2019

Potential Influence on Clinical Trials of Long-Term Survivors of Stage IV Non-small cell Lung Cancer.

JNCI Cancer Spectr 2019 Jun 15;3(2):pkz010. Epub 2019 Apr 15.

Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncics/pkz010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563418PMC
June 2019

Schlafen 11 (SLFN11), a restriction factor for replicative stress induced by DNA-targeting anti-cancer therapies.

Pharmacol Ther 2019 09 23;201:94-102. Epub 2019 May 23.

Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pharmthera.2019.05.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708787PMC
September 2019

Targeting mesothelin in ovarian cancer.

Oncotarget 2018 Nov 16;9(90):36050-36051. Epub 2018 Nov 16.

Thoracic and GI Malignancies Branch, National Cancer Institute, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.26350DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281414PMC
November 2018

Characteristics and Outcomes of Small Cell Lung Cancer Detected by CT Screening.

Chest 2018 12 3;154(6):1284-1290. Epub 2018 Aug 3.

Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chest.2018.07.029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335258PMC
December 2018

Scientific Advances and New Frontiers in Mesothelioma Therapeutics.

J Thorac Oncol 2018 09;13(9):1269-1283

Thoracic and Gastrointestinal Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.06.011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643278PMC
September 2018

Overcoming Resistance to DNA-Targeted Agents by Epigenetic Activation of Schlafen 11 ( Expression with Class I Histone Deacetylase Inhibitors.

Clin Cancer Res 2018 04 1;24(8):1944-1953. Epub 2018 Feb 1.

Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-17-0443DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5899656PMC
April 2018

Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.

J Clin Oncol 2018 05 18;36(13):1343-1373. Epub 2018 Jan 18.

Hedy L. Kindler and Samuel G. Armato III, The University of Chicago, Chicago, IL; Nofisat Ismaila, American Society of Clinical Oncology; Mary Hesdorffer, Mesothelioma Applied Research Foundation, Alexandria, VA; Raphael Bueno, Harvard Medical School, Boston, MA; Thierry Jahan, University of California San Francisco, San Francisco, CA; Clyde Michael Jones, Baptist Cancer Center Physicians Foundation, Memphis, TN; Markku Miettinen, Anish Thomas and Raffit Hassan, Center for Cancer Research, National Cancer Institute, Bethesda, MD; Harvey Pass and Daniel Sterman, New York University Langone Medical Center; and Andreas Rimner and Valerie Rusch, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.76.6394
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.76.6394DOI Listing
May 2018

Phase I Study of ATR Inhibitor M6620 in Combination With Topotecan in Patients With Advanced Solid Tumors.

J Clin Oncol 2018 06 18;36(16):1594-1602. Epub 2017 Dec 18.

Anish Thomas, Christophe E. Redon, Linda Sciuto, Emerson Padiernos, Min-Jung Lee, Akira Yuno, Sunmin Lee, Arun Rajan, Udayan Guha, Haobin Chen, Raffit Hassan, Christine C. Alewine, Eva Szabo, Seth M. Steinberg, James H. Doroshow, Mirit I. Aladjem, Jane B. Trepel, and Yves Pommier, National Cancer Institute, Bethesda; Jiuping Ji, Yiping Zhang, Lan Tran, William Yutzy, and Robert J. Kinders, Frederick National Laboratory for Cancer Research, Frederick, MD; and Susan E. Bates, Columbia University Medical Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.6915DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978471PMC
June 2018

Patterns of care and survival among patients with malignant mesothelioma in the United States.

Lung Cancer 2017 10 10;112:102-108. Epub 2017 Aug 10.

National Cancer Institute, Bethesda, MD, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.08.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5726440PMC
October 2017

Thymic epithelial tumors and metastasis to the brain: a case series and systematic review.

Transl Lung Cancer Res 2017 Oct;6(5):588-599

Thoracic and Gastrointestinal Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2017.08.06DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653528PMC
October 2017

CTLA-4 blockade in mesothelioma: ineffective or reason for optimism?

Lancet Oncol 2017 09 17;18(9):1150-1151. Epub 2017 Jul 17.

Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(17)30511-9DOI Listing
September 2017

Clinical Features and Outcomes of Tunica Vaginalis Mesothelioma: A Case Series From the National Institutes of Health.

Clin Genitourin Cancer 2017 10 22;15(5):e871-e875. Epub 2017 May 22.

Urologic Oncology Branch, National Cancer Institute, National Institute of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2017.04.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623092PMC
October 2017

DNA-Targeted Precision Medicine; Have we Been Caught Sleeping?

Trends Cancer 2017 01;3(1):2-6

Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.trecan.2016.11.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461960PMC
January 2017

Temozolomide in the Era of Precision Medicine.

Cancer Res 2017 02 3;77(4):823-826. Epub 2017 Feb 3.

Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-16-2983DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313339PMC
February 2017

Metastatic lung cancer in the age of targeted therapy: improving long-term survival.

Transl Lung Cancer Res 2016 Dec;5(6):727-730

Thoracic and Gastrointestinal Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2016.11.08DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5233873PMC
December 2016

Temporal patterns of care and outcomes of non-small cell lung cancer patients in the United States diagnosed in 1996, 2005, and 2010.

Lung Cancer 2017 01 29;103:66-74. Epub 2016 Nov 29.

National Cancer Institute, Division of Cancer Control and Population Sciences, Healthcare Delivery Research Program, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.11.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5198713PMC
January 2017

Mesothelin Immunotherapy for Cancer: Ready for Prime Time?

J Clin Oncol 2016 12 31;34(34):4171-4179. Epub 2016 Oct 31.

Raffit Hassan, Anish Thomas, Christine Alewine, and Ira Pastan, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda; and Dung T. Le and Elizabeth M. Jaffee, Sidney Kimmel Cancer Center, Johns Hopkins University, Baltimore, MD.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.68.3672
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.68.3672DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477819PMC
December 2016

Expression of mesothelin in thymic carcinoma and its potential therapeutic significance.

Lung Cancer 2016 11 28;101:104-110. Epub 2016 Sep 28.

Thoracic and Gastrointestinal Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.09.015DOI Listing
November 2016

Small cell lung cancer: Time to revisit DNA-damaging chemotherapy.

Sci Transl Med 2016 07;8(346):346fs12

Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.aaf6282DOI Listing
July 2016

Antibody-drug conjugates for cancer therapy.

Lancet Oncol 2016 06;17(6):e254-e262

Thoracic and GI Oncology Branch, National Cancer Institute, Bethesda, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S14702045163003
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(16)30030-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601617PMC
June 2016

Real-World Patterns of EGFR Testing and Treatment with Erlotinib for Non-Small Cell Lung Cancer in the United States.

PLoS One 2016 13;11(6):e0156728. Epub 2016 Jun 13.

Thoracic and Gastrointestinal Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0156728PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905679PMC
July 2017

Should anti-mesothelin therapies be explored in lung cancer?

Authors:
Anish Thomas

Expert Rev Anticancer Ther 2016 07 31;16(7):677-9. Epub 2016 May 31.

a Thoracic and GI Oncology Branch, Center for Cancer Research , National Cancer Institute , Bethesda , MD , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2016.1192472DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215820PMC
July 2016

Expression of tropomyosin 2 gene isoforms in human breast cancer cell lines.

Oncol Rep 2016 Jun 4;35(6):3143-50. Epub 2016 Apr 4.

Division of Hematology/Oncology, Department of Medicine, Upstate Medical University, Syracuse, NY 13210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2016.4732DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869935PMC
June 2016

Mutations in Latinos From the United States and Latin America.

J Glob Oncol 2016 Oct 9;2(5):259-267. Epub 2016 Mar 9.

, Knight Cancer Institute, Oregon Health and Science University, Portland, OR; , , , , , , , and , Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; , Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru; , Instituto Nacional de Cancerologia, Mexico City, Mexico; , Hospital Oncologico Luis Razetti, Caracas, Venezuela; , Denver Health Medical Center, University of Colorado, Denver, CO; , Kettering Cancer and Blood Specialists, Kettering, OH; and , Facultad de Medicina de la Universidad del Valle, Cochabamba, Bolivia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JGO.2015.002105DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493261PMC
October 2016

Alterations of immune cell subsets in relapsed, thymoma-associated minimal change disease: A case report.

Oncol Lett 2015 Aug 5;10(2):1155-1158. Epub 2015 Jun 5.

Thoracic and Gastrointestinal Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-1906, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2015.3325DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509017PMC
August 2015

Distinctive clinical characteristics of malignant mesothelioma in young patients.

Oncotarget 2015 Jun;6(18):16766-73

Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599306PMC
http://dx.doi.org/10.18632/oncotarget.4414DOI Listing
June 2015

Reply to A. Stenzinger et al.

J Clin Oncol 2015 Sep 13;33(25):2824. Epub 2015 Jul 13.

Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.7323DOI Listing
September 2015

Trends and Characteristics of Young Non-Small Cell Lung Cancer Patients in the United States.

Front Oncol 2015 26;5:113. Epub 2015 May 26.

Lombardi Cancer Center, Georgetown University , Washington DC , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2015.00113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4443720PMC
June 2015

Refining the treatment of NSCLC according to histological and molecular subtypes.

Nat Rev Clin Oncol 2015 Sep 12;12(9):511-26. Epub 2015 May 12.

Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, 3970 Reservoir Road North West, Washington, DC 20057, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nrclinonc.2015.90
Publisher Site
http://dx.doi.org/10.1038/nrclinonc.2015.90DOI Listing
September 2015

Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial.

J Clin Oncol 2015 Mar 9;33(9):1000-7. Epub 2015 Feb 9.

Ariel Lopez-Chavez, Anish Thomas, Arun Rajan, Mark Raffeld, Betsy Morrow, Ronan Kelly, Corey Allan Carter, Udayan Guha, Keith Killian, Christopher C. Lau, Zied Abdullaev, Liqiang Xi, Svetlana Pack, Paul S. Meltzer, David J. Liewehr, Seth M. Steinberg, Arlene Berman, Eva Szabo, Yisong Wang, and Giuseppe Giaccone, National Cancer Institute; Austin Doyle, Cancer Therapy Evaluation Program, Bethesda, MD; Ariel Lopez-Chavez, Christopher L. Corless, Alan Sandler, Carol Beadling, and Andrea Warrick, Knight Cancer Institute, Oregon Health and Science University, Portland, OR; Ariel Lopez-Chavez, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL; and Yisong Wang and Giuseppe Giaccone, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/02/03/JCO.2014.58
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.58.2007
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.58.2007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4356709PMC
March 2015

Multiorgan autoimmune manifestations associated with thymoma.

J Thorac Oncol 2015 Feb;10(2):e5-7

*GI Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland; and †Medical Oncology, Lombardi Cancer Center, Georgetown University, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000324DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306236PMC
February 2015

Mutations of epigenetic regulatory genes are common in thymic carcinomas.

Sci Rep 2014 Dec 8;4:7336. Epub 2014 Dec 8.

1] Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892 [2] Lombardi Comprehensive Cancer Center, Georgetown University, Washington DC 20007.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep07336DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4258655PMC
December 2014

Biomarkers in early-stage non-small-cell lung cancer: current concepts and future directions.

J Thorac Oncol 2014 Nov;9(11):1609-17

*Thoracic and Gastrointestinal Oncology Branch, National Cancer Institute, Bethesda, Maryland; and †Department of Medicine, Division of Hematology/Oncology, Lombardi Cancer Center, Georgetown University, Washington, DC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000302DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4254270PMC
November 2014

Immunotherapy for non-small-cell lung cancer.

Expert Opin Biol Ther 2014 Aug 30;14(8):1061-4. Epub 2014 May 30.

National Cancer Institute, National Institutes of Health, Center for Cancer Research, Thoracic and GI Oncology Branch , Building 10-CRC/4-5330, Bethesda, MD 20892 , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2014.925874DOI Listing
August 2014

Novel biologic therapies for thymic epithelial tumors.

Front Oncol 2014 7;4:103. Epub 2014 May 7.

Thoracic and Gastrointestinal Oncology Branch, National Cancer Institute, National Institutes of Health , Bethesda, MD , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2014.00103DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019864PMC
May 2014

Characterization of fibroblast growth factor receptor 1 in small-cell lung cancer.

J Thorac Oncol 2014 Apr;9(4):567-71

*Medical Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; †Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; and ‡Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000089DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705182PMC
April 2014

From platinum compounds to targeted therapies in advanced thoracic malignancies.

Anticancer Res 2014 Jan;34(1):477-82

Oregon Health and Sciences University 3181 SW Sam Jackson Park Rd, Portland, OR, U.S.A.

View Article

Download full-text PDF

Source
January 2014

Major cancer regressions in mesothelioma after treatment with an anti-mesothelin immunotoxin and immune suppression.

Sci Transl Med 2013 Oct;5(208):208ra147

Laboratory of Molecular Biology, Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.3006941DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369691PMC
October 2013

Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapy.

Front Oncol 2013 Oct 9;3:261. Epub 2013 Oct 9.

University of Zagreb, School of Medicine, Department for Respiratory Diseases Jordanovac, University Hospital Center Zagreb , Zagreb , Croatia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2013.00261DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793201PMC
October 2013

"Pseudocavitation" in thymic carcinoma during treatment with sunitinib.

J Thorac Oncol 2013 Apr;8(4):511-2

Medical Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318284378fDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602913PMC
April 2013

New insights into understanding the mechanisms, pathogenesis, and management of malignant mesotheliomas.

Am J Pathol 2013 Apr 8;182(4):1065-77. Epub 2013 Feb 8.

Department of Pathology, University of Vermont College of Medicine, Burlington, Vermont 05405-0068, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2012.12.028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657618PMC
April 2013

Farletuzumab in lung cancer.

Lung Cancer 2013 Apr 26;80(1):15-8. Epub 2013 Jan 26.

Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2012.12.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3595339PMC
April 2013

Hepatoid carcinoma of the lung with anaplastic lymphoma kinase gene rearrangement.

J Thorac Oncol 2012 Nov;7(11):e29-31

Medical Oncology Branch Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3182697a23DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474982PMC
November 2012

Response to crizotinib in ROS1-rearranged non-small-cell lung cancer.

J Clin Oncol 2012 Sep 13;30(27):3425-6; author reply 3426. Epub 2012 Aug 13.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.42.4556DOI Listing
September 2012

Immunotherapies for non-small-cell lung cancer and mesothelioma.

Lancet Oncol 2012 Jul 28;13(7):e301-10. Epub 2012 Jun 28.

Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(12)70126-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317076PMC
July 2012

Tyrosine kinase inhibitors in lung cancer.

Hematol Oncol Clin North Am 2012 Jun 2;26(3):589-605, viii. Epub 2012 Mar 2.

Medical Oncology Branch, National Cancer Institution, Room 12N226, 10 Center Drive, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2012.02.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334853PMC
June 2012

Second malignancies after multiple myeloma: from 1960s to 2010s.

Blood 2012 Mar 6;119(12):2731-7. Epub 2012 Feb 6.

Multiple Myeloma Section, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2011-12-381426DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3327452PMC
March 2012

Absence of mutation at the 5'-upstream promoter region of the TPM4 gene from cardiac mutant axolotl (Ambystoma mexicanum).

Cardiovasc Toxicol 2011 Sep;11(3):235-43

Department of Medicine, SUNY Upstate Medical University, Syracuse, NY 13210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12012-011-9117-zDOI Listing
September 2011

Electrocardiographic detection of emphysema.

Am J Cardiol 2011 Apr;107(7):1090-2

University of Massachusetts Medical School, Worcester, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjcard.2010.11.039DOI Listing
April 2011

Short communication: no evidence of HTLV-3 and HTLV-4 infection in New York State subjects at risk for retroviral infection.

AIDS Res Hum Retroviruses 2010 Nov 7;26(11):1229-31. Epub 2010 Oct 7.

Division of Hematology/Oncology, Department of Medicine, State University of New York , Upstate Medical University, Syracuse, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/aid.2010.0079DOI Listing
November 2010

LGL leukemia and HTLV.

AIDS Res Hum Retroviruses 2010 Jan;26(1):33-40

Department of Medicine, State University of New York, Upstate Medical University, Syracuse, 13202, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/aid.2009.0124DOI Listing
January 2010

Methyldopa-induced autoimmune haemolytic anaemia revisited.

N Z Med J 2009 Aug 21;122(1301):53-6. Epub 2009 Aug 21.

Department of Medicine, SUNY Upstate Medical University, Syracuse, NY-13202, USA.

View Article

Download full-text PDF

Source
August 2009

Colonic necrosis due to oral kayexalate in a critically-ill patient.

Am J Med Sci 2009 Apr;337(4):305-6

Department of Medicine, SUNY Upstate Medical University, Syracuse, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MAJ.0b013e31818dd715DOI Listing
April 2009

Expression of Nkx2.5 in wild type, cardiac mutant, and thyroxine-induced metamorphosed hearts of the Mexican axolotl.

Cardiovasc Toxicol 2009 Mar 4;9(1):13-20. Epub 2009 Feb 4.

Department of Medicine, SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12012-009-9030-xDOI Listing
March 2009